Russell Investments Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.28M | Buy |
39,085
+15,336
| +65% | +$552K | ﹤0.01% | 2334 |
|
|
2026
Q1 | $840K | Sell |
23,749
-1,821
| -7% | -$74.1K | ﹤0.01% | 2297 |
|
|
2025
Q4 | $1.04M | Sell |
25,570
-735
| -3% | -$32K | ﹤0.01% | 2211 |
|
|
2025
Q3 | $1.24M | Buy |
26,305
+3,821
| +17% | +$198K | ﹤0.01% | 2109 |
|
|
2025
Q2 | $1.17M | Sell |
22,484
-9,943
| -31% | -$546K | ﹤0.01% | 1990 |
|
|
2025
Q1 | $1.96M | Buy |
32,427
+14,910
| +85% | +$961K | ﹤0.01% | 1710 |
|
|
2024
Q4 | $1.2M | Sell |
17,517
-1,978
| -10% | -$138K | ﹤0.01% | 1920 |
|
|
2024
Q3 | $1.4M | Sell |
19,495
-8,960
| -31% | -$632K | ﹤0.01% | 1874 |
|
|
2024
Q2 | $1.97M | Buy |
28,455
+23
| +0.1% | +$1.68K | ﹤0.01% | 1640 |
|
|
2024
Q1 | $2.28M | Sell |
28,432
-15,580
| -35% | -$1.39M | ﹤0.01% | 1585 |
|
|
2023
Q4 | $4.82M | Sell |
44,012
-824
| -2% | -$85.2K | 0.01% | 1146 |
|
|
2023
Q3 | $4.52M | Sell |
44,836
-373
| -0.8% | -$42.9K | 0.01% | 1132 |
|
|
2023
Q2 | $6.14M | Sell |
45,209
-2,150
| -5% | -$262K | 0.01% | 1008 |
|
|
2023
Q1 | $4.92M | Buy |
47,359
+10,531
| +29% | +$1.02M | 0.01% | 1113 |
|
|
2022
Q4 | $3.26M | Sell |
36,828
-18,574
| -34% | -$1.54M | 0.01% | 1315 |
|
|
2022
Q3 | $4.44M | Buy |
55,402
+866
| +2% | +$81.7K | 0.01% | 1116 |
|
|
2022
Q2 | $5.22M | Sell |
54,536
-1,360
| -2% | -$163K | 0.01% | 1071 |
|
|
2022
Q1 | $8.3M | Sell |
55,896
-6,429
| -10% | -$898K | 0.01% | 906 |
|
|
2021
Q4 | $8.83M | Sell |
62,325
-1,136
| -2% | -$161K | 0.01% | 967 |
|
|
2021
Q3 | $8.3M | Buy |
63,461
+5,778
| +10% | +$756K | 0.01% | 975 |
|
|
2021
Q2 | $7.93M | Sell |
57,683
-1,540
| -3% | -$211K | 0.01% | 1065 |
|
|
2021
Q1 | $7.73M | Buy |
59,223
+10,648
| +22% | +$1.28M | 0.01% | 1110 |
|
|
2020
Q4 | $5.44M | Sell |
48,575
-15,928
| -25% | -$1.51M | 0.01% | 1196 |
|
|
2020
Q3 | $5.07M | Buy |
64,503
+6,814
| +12% | +$556K | 0.01% | 1112 |
|
|
2020
Q2 | $4.14M | Sell |
57,689
-9,977
| -15% | -$694K | 0.01% | 1209 |
|
|
2020
Q1 | $3.86M | Buy |
67,666
+30,980
| +84% | +$2.86M | 0.01% | 1095 |
|
|
2019
Q4 | $4.1M | Sell |
36,686
-14,731
| -29% | -$1.57M | 0.01% | 1333 |
|
|
2019
Q3 | $4.94M | Buy |
51,417
+20,356
| +66% | +$1.91M | 0.01% | 1205 |
|
|
2019
Q2 | $2.66M | Hold |
31,061
| – | – | 0.01% | 1538 |
|
|
2019
Q1 | $2.58M | Buy |
31,061
+9,404
| +43% | +$683K | ﹤0.01% | 1587 |
|
|
2018
Q4 | $1.39M | Sell |
21,657
-2,085
| -9% | -$143K | ﹤0.01% | 1775 |
|
|
2018
Q3 | $1.88M | Hold |
23,742
| – | – | ﹤0.01% | 1794 |
|
|
2018
Q2 | $1.74M | Buy |
+23,742
| New | +$1.61M | ﹤0.01% | 1834 |
|
|
2017
Q4 | – | Sell |
-17,363
| Closed | -$911K | – | 2957 |
|
|
2017
Q3 | $911K | Sell |
17,363
-51,253
| -75% | -$2.57M | ﹤0.01% | 2184 |
|
|
2017
Q2 | $3.5M | Sell |
68,616
-11,870
| -15% | -$587K | 0.01% | 1420 |
|
|
2017
Q1 | $3.57M | Sell |
80,486
-3,812
| -5% | -$164K | 0.01% | 1415 |
|
|
2016
Q4 | $3.74M | Buy |
+84,298
| New | +$3.58M | 0.01% | 1419 |
|
Other funds holding CNMD
CB
GT
TCM
Russell Investments Group's CNMD Position: Q2 2026 in Review
Russell Investments Group increased its CONMED (CNMD) stake by 65% in Q2 2026, buying an estimated $552K and bringing the position to 39,085 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2334.
Russell Investments Group first reported a position in CNMD in Q4 2016 and has held it in 37 quarters since. The position peaked at $8.83M in Q4 2021. 101 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Russell Investments Group held 39,085 shares of CONMED worth $1.28M as of Q2 2026.
- Russell Investments Group bought 15,336 CONMED shares in Q2 2026, an estimated $552K.
- CONMED made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2334 holding.
- Russell Investments Group first reported a position in CONMED in Q4 2016 and has held it in 37 quarters since.
- Russell Investments Group's CONMED position peaked at $8.83M in Q4 2021.
- 101 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.